Further to the Chancellor\u2019s Autumn Statement, Investment Zones are being refocused to catalyse a number of the highest potential knowledge intensive growth clusters to boost productivity, growth and job creation. These will be based around the Chancellor's five priority sectors.<\/p>
We will work closely with Mayors, the Devolved Administrations, local authorities, businesses, and other local partners.<\/p>
I recently met with Maritime UK, and look forward to further engagement as this policy develops.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4737", "label" : {"_value" : "Biography information for Dehenna Davison"} } , "answeringMemberConstituency" : {"_value" : "Bishop Auckland"} , "answeringMemberPrinted" : {"_value" : "Dehenna Davison"} , "dateOfAnswer" : {"_value" : "2023-02-08", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "136743"} , {"_value" : "137997"} , {"_value" : "137998"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-02-08T15:33:39.697Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "211"} , "answeringDeptShortName" : {"_value" : "Levelling Up, Housing and Communities"} , "answeringDeptSortName" : {"_value" : "Levelling Up, Housing and Communities"} , "date" : {"_value" : "2023-02-02", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Shipping: Investment Zones"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Levelling Up, Housing and Communities, how his Department will work with the maritime sector to refocus the Investment Zones programme.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4653", "label" : {"_value" : "Biography information for Stephen Morgan"} } , "tablingMemberConstituency" : {"_value" : "Portsmouth South"} , "tablingMemberPrinted" : [{"_value" : "Stephen Morgan"} ], "uin" : "137999"} , {"_about" : "http://data.parliament.uk/resources/1582865", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1582865/answer", "answerText" : {"_value" : "
The UK Government cannot disclose information on residency status of those on the sanctions list. Details of all sanctioned individuals and entities are listed on the UK sanctions list, which can be found on gov.uk:<\/p>
https://www.gov.uk/government/publications/the-uk-sanctions-list<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4531", "label" : {"_value" : "Biography information for Anne-Marie Trevelyan"} } , "answeringMemberConstituency" : {"_value" : "Berwick-upon-Tweed"} , "answeringMemberPrinted" : {"_value" : "Anne-Marie Trevelyan"} , "dateOfAnswer" : {"_value" : "2023-02-09", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-02-09T15:20:05.37Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "208"} , "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "date" : {"_value" : "2023-02-02", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Russia: Sanctions"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, how many Russian nationals subject to UK sanctions are resident in the UK.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4617", "label" : {"_value" : "Biography information for Matt Western"} } , "tablingMemberConstituency" : {"_value" : "Warwick and Leamington"} , "tablingMemberPrinted" : [{"_value" : "Matt Western"} ], "uin" : "137890"} , {"_about" : "http://data.parliament.uk/resources/1582714", "AnsweringBody" : [{"_value" : "Cabinet Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1582714/answer", "answerText" : {"_value" : "
The information requested falls under the remit of the UK Statistics Authority.<\/p>
<\/p>
A response to the Hon. Member's Parliamentary Question of 1 February is attached.<\/p>
<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4507", "label" : {"_value" : "Biography information for Sir Jeremy Quin"} } , "answeringMemberConstituency" : {"_value" : "Horsham"} , "answeringMemberPrinted" : {"_value" : "Jeremy Quin"} , "attachment" : {"_about" : "http://data.parliament.uk/resources/1582714/answer/attachment/1", "fileName" : {"_value" : "PQ137833.pdf"} , "title" : "UKSA Response"} , "dateOfAnswer" : {"_value" : "2023-02-09", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-02-09T17:11:59.787Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "53"} , "answeringDeptShortName" : {"_value" : "Cabinet Office"} , "answeringDeptSortName" : {"_value" : "Cabinet Office"} , "date" : {"_value" : "2023-02-01", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mortality Rates"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Minister for the Cabinet Office, whether he has made an assessment of the adequacy of ONS data on excess deaths.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4638", "label" : {"_value" : "Biography information for Mr Tanmanjeet Singh Dhesi"} } , "tablingMemberConstituency" : {"_value" : "Slough"} , "tablingMemberPrinted" : [{"_value" : "Mr Tanmanjeet Singh Dhesi"} ], "uin" : "137833"} , {"_about" : "http://data.parliament.uk/resources/1582716", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1582716/answer", "answerText" : {"_value" : "
The life sciences sector is among the most valuable and strategically important in the United Kingdom\u2019s economy. The latest edition of the Government\u2019s Life Sciences Competitiveness Indicators shows that in 2020, the UK ranked sixth out of 10 comparator countries for our share of patients recruited to a subset of commercial global studies for novel medicines. The UK also ranked seventh for the time taken between clinical trial application and first dose to first patient. This is up from tenth in 2019.<\/p>
The indicators also show that, in 2020, the UK pharmaceutical industry spent over £5 billion on research and development (R&D) and has consistently been the largest industry to spend on R&D in the UK, making up more than a fifth of all R&D performed by industry between 2014 and 2020.<\/p>
The National Health Service in England is internationally competitive in adopting innovative medicines. Industry data shows that there are five treatments available in England for every four in Europe and almost a third more cancer drugs.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"} } , "answeringMemberConstituency" : {"_value" : "Colchester"} , "answeringMemberPrinted" : {"_value" : "Will Quince"} , "dateOfAnswer" : {"_value" : "2023-02-09", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-02-09T13:56:52.207Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-02-01", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Drugs: Manufacturing Industries"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will make an assessment of (a) the competitiveness of the UK pharmaceutical industry for (i) conducting clinical trials and (ii) research and development and (b) the impact of the level of use of innovative medicines in the NHS on outcomes for patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "137769"} , {"_about" : "http://data.parliament.uk/resources/1582717", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1582717/answer", "answerText" : {"_value" : "